Published in Transplantation on September 15, 2014
A systematic review of the associations between dose regimens and medication compliance. Clin Ther (2001) 9.23
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant (2009) 6.43
Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care (1998) 5.76
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med (1999) 2.44
Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation (2004) 2.26
The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant (2004) 2.18
Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm (2003) 2.16
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis (2008) 1.84
Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant (2004) 1.82
Nonadherence consensus conference summary report. Am J Transplant (2009) 1.61
Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol (2007) 1.60
Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant (2001) 1.58
Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol (2005) 1.54
Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant (2004) 1.54
Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis (2004) 1.45
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33
Medication noncompliance and its implications in transplant recipients. Drugs (2007) 1.26
Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood (2004) 1.16
Self-efficacy, self-care behaviours and quality of life of kidney transplant recipients. J Adv Nurs (2010) 1.02
Late renal allograft loss: noncompliance masquerading as chronic rejection. Transplant Proc (1999) 1.01
Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Nephrol Dial Transplant (2005) 0.89
Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant (2013) 0.87
Who is caring for kidney transplant patients? Variation by region, transplant center, and patient characteristics. Am J Nephrol (2009) 0.86
Kidney transplant patients' perceptions, beliefs, and barriers related to regular nephrology outpatient visits. Am J Kidney Dis (2010) 0.84
Enhancing transplant patients' adherence to medication therapy. Clin Transplant (2002) 0.84
Culturally responsive interventions to enhance immunosuppressive medication adherence in older African American kidney transplant recipients. Prog Transplant (2006) 0.83
The expanding role of the transplant pharmacist in the multidisciplinary practice of transplantation. Clin Transplant (2004) 0.82
Multidisciplinary chronic kidney disease management improves survival on dialysis. J Nephrol (2004) 0.81
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med (2004) 10.35
Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med (2003) 9.29
International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol (2006) 7.51
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer (2008) 6.96
Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (2003) 6.85
Race and trust in the health care system. Public Health Rep (2003) 6.74
Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health (2004) 5.79
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33
Cultural competence: a systematic review of health care provider educational interventions. Med Care (2005) 5.09
Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA (2003) 4.81
Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA (2004) 4.54
Clinical information technologies and inpatient outcomes: a multiple hospital study. Arch Intern Med (2009) 4.50
Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA (2003) 4.33
Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med (2002) 4.17
Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine (Baltimore) (2008) 4.14
Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med (2008) 3.72
Systematic review: the value of the periodic health evaluation. Ann Intern Med (2007) 3.62
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med (2004) 3.59
Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA (2004) 3.46
Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. Med Care (2002) 3.37
Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA (2003) 3.25
Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol (2010) 3.12
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96
Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol (2002) 2.96
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med (2009) 2.84
Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med (2005) 2.82
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74
Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol (2005) 2.74
Statin use and sepsis events [corrected] in patients with chronic kidney disease. JAMA (2007) 2.69
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis (2006) 2.64
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol (2002) 2.58
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int (2009) 2.53
Postdischarge environmental and socioeconomic factors and the likelihood of early hospital readmission among community-dwelling Medicare beneficiaries. Gerontologist (2008) 2.53
Association between screening for osteoporosis and the incidence of hip fracture. Ann Intern Med (2005) 2.52
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis (2010) 2.47
Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol (2007) 2.46
A systematic review of the methodological rigor of studies evaluating cultural competence training of health professionals. Acad Med (2005) 2.44
Domino paired kidney donation: a strategy to make best use of live non-directed donation. Lancet (2006) 2.38
Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24
Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol (2006) 2.23
Inflammatory cells in ischemic acute renal failure. Kidney Int (2004) 2.20
Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis (2009) 2.18
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
Improving health care quality for racial/ethnic minorities: a systematic review of the best evidence regarding provider and organization interventions. BMC Public Health (2006) 2.15
Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA (2005) 2.15
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2007) 2.14
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med (2008) 2.11
The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol (2008) 2.08
Determinants of willingness to donate living related and cadaveric organs: identifying opportunities for intervention. Transplantation (2002) 2.06
Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology (2004) 2.06
Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol (2008) 2.03
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation. Transplantation (2014) 2.00
Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial. Am J Kidney Dis (2012) 2.00
The role of cultural diversity climate in recruitment, promotion, and retention of faculty in academic medicine. J Gen Intern Med (2005) 2.00
The innate immune response in ischemic acute kidney injury. Clin Immunol (2008) 1.98
Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol (2004) 1.97
Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension (2009) 1.88
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 1.88
The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int (2008) 1.83
Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension (2010) 1.81
Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. J Clin Epidemiol (2006) 1.79
Association between hospitals caring for a disproportionately high percentage of minority trauma patients and increased mortality: a nationwide analysis of 434 hospitals. Arch Surg (2011) 1.77
A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol (2006) 1.77
B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol (2003) 1.73
25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol (2009) 1.71
Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2005) 1.71
CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.71
Race and health insurance are predictors of hospitalized Crohn's disease patients undergoing bowel resection. Inflamm Bowel Dis (2007) 1.70
Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol (2011) 1.70
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70
Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J Am Soc Nephrol (2004) 1.69
Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clin Trials (2006) 1.68
Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis (2010) 1.68
Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer (2007) 1.67
Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int (2008) 1.67
Informing the debate: rates of kidney transplantation in nations with presumed consent. Ann Intern Med (2010) 1.65
Age and comorbidities are effect modifiers of gender disparities in renal transplantation. J Am Soc Nephrol (2009) 1.64
Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: The Cardiovascular Health Study. Soc Sci Med (2007) 1.64
Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int (2013) 1.63
Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases. Ann Surg (2004) 1.63
Referral of patients to specialists: factors affecting choice of specialist by primary care physicians. Ann Fam Med (2004) 1.62
Concomitant surgery with laparoscopic live donor nephrectomy. Am J Transplant (2003) 1.62